Latest Developments in Asia Pacific Digital Therapeutics Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Asia Pacific Digital Therapeutics Market

  • Healthcare IT
  • Jun 2024
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In May 2024, CureApp, Inc. (Japan), a pioneer in digital therapeutics, launched CureApp SC, an innovative smoking cessation DTx platform, in collaboration with the Japanese Ministry of Health. This clinically approved app-based therapy integrates behavioral guidance with AI-driven insights, enhancing patient outcomes through real-time feedback and personalized support. The launch reinforces Japan’s leadership in regulatory acceptance and clinical deployment of DTx solutions
  • In March 2024, Wellthy Therapeutics (India) partnered with a major healthcare provider to deploy its chronic disease management platform across multiple cities in India. The multilingual, AI-powered DTx platform targets diabetes and cardiovascular diseases, enabling personalized care plans and remote monitoring. This strategic move expands digital health access to tier 2 and tier 3 regions, demonstrating the scalability of localized DTx solutions
  • In February 2024, JOGO Health (India) introduced its neuroplasticity-based digital therapeutic in South Korea, aimed at treating stroke and incontinence through wearable biofeedback devices. The expansion into a new market highlight growing cross-border interest in non-invasive, software-driven therapies and showcases India’s innovation footprint in the global DTx landscape
  • In January 2024, Samsung Medical Center (South Korea) launched a pilot project integrating digital therapeutics for sleep disorders and cognitive behavioral therapy (CBT) using a hospital-linked app platform. The project is part of a broader initiative to embed DTx into traditional care delivery, with real-time monitoring and clinical oversight, further advancing hybrid digital-health models in the country
  • In December 2023, Tunstall Healthcare (Australia) collaborated with local public health authorities to implement a digital health intervention program for elderly patients with chronic conditions. The program combines wearable devices and DTx software to remotely track patient progress, prevent hospital readmissions, and promote independent living. This initiative reflects Australia's growing commitment to digital aging solutions and value-based care models